Although there’s no official clinical diagnosis, the psychiatric and psychological communities have names for the phenomenon of worrying about the Earth’s fate: “climate distress,” “climate grief,” “climate anxiety” or “eco-anxiety.” The concept also is gradually making its way into the public consciousness in television shows and movies.
A wide variety of medications used to treat allergies, insomnia, leaky bladders, diarrhea, dizziness, motion sickness, asthma, Parkinson’s disease, chronic obstructive pulmonary disease and psychiatric disorders can interfere with cognition in older patients.
An estimated 18 million American adults have sleep apnea. The go-to treatment — a CPAP machine — offers a healthy restful night’s sleep, but many people struggle to use it. As many as 50% of patients stop using the device.
Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.
Over the past decade, more than 350 workers nationwide have died from heat-related illness, and tens of thousands have had heat-related problems serious enough that they missed at least one day of work. Proposed federal legislation, modeled on California regulations, would create the first national standards for protecting workers from heat-related stress.
The U.S. Preventive Services Task Force recommended that people who are at high risk of contracting HIV take PrEP, a preventive treatment. The decision means most health plans will be required to cover the drugs without charging patients. But the recommendation doesn’t apply to the other clinical and lab services people need.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
A new report by the inspector general for HHS shows prescriptions to treat opioid addiction are way up in recent years, while prescriptions for the painkillers have fallen.
KHN, in collaboration with PBS NewsHour, reports on the skyrocketing cost of insulin — and the trend’s deadly consequences. The price in the U.S. nearly doubled from 2012 to 2016, prompting some patients and activists to travel to Canada, where insulin can be 90% cheaper.
